Tolvaptan- and Tolvaptan-Metabolite-Responsive T Cells in Patients with Drug-Induced Liver Injury. (2020)
Attributed to:
Definition of the naturally-processed drug-peptide adducts that can act as functional T-cell antigens
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acs.chemrestox.0c00328
PubMed Identifier: 33085478
Publication URI: http://europepmc.org/abstract/MED/33085478
Type: Journal Article/Review
Volume: 33
Parent Publication: Chemical research in toxicology
Issue: 11
ISSN: 0893-228X